Aberdeen Asset Management plc Rating Reiterated by Liberum Capital (ADN)
Aberdeen Asset Management plc (LON:ADN)‘s stock had its “buy” rating reaffirmed by investment analysts at Liberum Capital in a note issued to investors on Friday. They currently have a GBX 555 ($9.34) target price on the stock. Liberum Capital’s target price points to a potential upside of 36.94% from the stock’s previous close.
A number of other firms have also recently commented on ADN. Analysts at Credit Suisse reiterated a “neutral” rating on shares of Aberdeen Asset Management plc in a research note on Wednesday, July 30th. They now have a GBX 440 ($7.40) price target on the stock. Separately, analysts at Berenberg Bank cut their price target on shares of Aberdeen Asset Management plc from GBX 530 ($8.92) to GBX 510 ($8.58) in a research note on Tuesday, July 29th. They now have a “buy” rating on the stock. Finally, analysts at Societe Generale downgraded shares of Aberdeen Asset Management plc to a “hold” rating in a research note on Tuesday, July 29th. They now have a GBX 465 ($7.82) price target on the stock. Three analysts have rated the stock with a sell rating, five have given a hold rating and twelve have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of GBX 472.29 ($7.95).
Shares of Aberdeen Asset Management plc (LON:ADN) traded down 0.78% on Friday, hitting GBX 405.30. 3,174,665 shares of the company’s stock traded hands. Aberdeen Asset Management plc has a 52-week low of GBX 342.60 and a 52-week high of GBX 500.00. The stock’s 50-day moving average is GBX 442.4 and its 200-day moving average is GBX 423.1. The company’s market cap is £4.644 billion.
Aberdeen Asset Management PLC is a global asset management company investing across the four main asset classes of equity, fixed income, property and alternative investment strategies.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.